TriSalus Life Sciences (TLSI) Consolidated Net Income (2021 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Consolidated Net Income of $1.5 million for Q1 2026, up 114.83% year-over-year from $716367.9 in Q1 2025, and up 115.78% quarter-over-quarter from -$9.8 million in Q4 2025.
TriSalus Life Sciences (TLSI) Consolidated Net Income (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' Consolidated Net Income history runs 6 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Consolidated Net Income rose 114.83% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at -$27.3 million (changed 0.36% YoY), while the FY2025 annual figure was -$39.2 million, down 30.56% from the prior year.
- Consolidated Net Income for Q1 2026 stood at $1.5 million, up from -$9.8 million in the prior quarter.
- The five-year high for Consolidated Net Income was $2.8 million in Q1 2022, with the low at -$35.6 million in Q4 2023.
- The 5-year median for Consolidated Net Income is -$8.3 million (2025), against an average of -$9.0 million.
- Peak annual rise in Consolidated Net Income reached 958.66% in 2022, while the deepest fall reached 878.46% in 2022.
- TriSalus Life Sciences' Consolidated Net Income stood at -$22.5 million in 2022, then tumbled by 58.1% to -$35.6 million in 2023, then soared by 71.64% to -$10.1 million in 2024, then gained by 3.51% to -$9.8 million in 2025, then surged by 115.78% to $1.5 million in 2026.
- Business Quant data shows TLSI's Consolidated Net Income at $1.5 million in Q1 2026, -$9.8 million in Q4 2025, and -$10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 201.00 Mn |
| 10 | TriSalus Life Sciences | 304.31 Mn | 258.02 Mn | 9.90 Mn | -9.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.19 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -9.75 Mn |
| Sep 30, 2025 | -10.81 Mn |
| Jun 30, 2025 | -8.29 Mn |
| Mar 31, 2025 | -10.38 Mn |
| Dec 31, 2024 | -10.11 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -13.21 Mn |
| Dec 31, 2023 | -35.64 Mn |
| Sep 30, 2023 | -1.43 Mn |
| Jun 30, 2023 | -13.97 Mn |
| Mar 31, 2023 | -8.27 Mn |
| Dec 31, 2022 | -22.54 Mn |
| Sep 30, 2022 | -8.09 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 1.86 Mn |